Compare Mesoblast Limited (MESO) vs Nuscale Power Corporation (SMR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mesoblast Limited vs Nuscale Power Corporation — how do they compare? Mesoblast Limited trades at $16.38 (market cap $2.17B), while Nuscale Power Corporation trades at $8.86 (market cap $2.76B). The key difference: Nuscale Power Corporation is the larger of the two by market cap, and Mesoblast Limited is trading nearer its 52-week high, Nuscale Power Corporation nearer its low. Which is the better fit depends on your goals.
| MESO | SMR | |
|---|---|---|
Market Cap | $2.17B | $2.76B |
Sector | Technology | Utilities |
52-Week High | $20.96 | $53.43 |
52-Week Low | $12.88 | $7.64 |
Enterprise Value | $2.17B | $1.87B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →About Nuscale Power Corporation
NuScale Power Corporation is a leading developer of Small Modular Reactor (SMR) technology. The company's flagship product is a light water reactor SMR designed to generate clean, reliable, and scalable nuclear power. NuScale's technology is poised to address the global demand for carbon-free energy by offering a safer, smaller, and more flexible alternative to traditional large-scale nuclear power plants, with applications in electricity generation, desalination, and process heat.
Read more on SMR →
